By JOHN NAISH FOR THE DAILY MAIL
PUBLISHED: 22:38, 12 September 2022 | UPDATED: 14:58, 13 September 2022
When Professor Karol Sikora, one of Britain’s most eminent cancer experts, was asked to defend an equally distinguished oncologist, Professor Justin Stebbing, against being struck off by the General Medical Council (GMC), he robustly challenged the claims being made against his colleague.
The brilliance of the world-renowned Professor Stebbing had earned him a professorship at Imperial College London before the age of 40.
His fall from grace began in 2017, when an anonymous whistleblower sent a dossier to the GMC, alleging that he had unnecessarily tried to save dying patients in a manner that was ‘fundamentally inconsistent’ with their best interests.
ADVERTISEMENT
The allegation was that he had tried too hard and gone too far. Arguably, this was precisely why some of his patients had sought Professor Stebbing’s care in the first place, after their own doctors had told them there was no more that could be done.
But last November, at the end of the disciplinary hearing, the GMC’s Medical Practitioners Tribunal Service (MPTS) panel ruled that Professor Stebbing’s behaviour had breached ‘the very core of the Hippocratic Oath’, and that his fitness to practise was impaired.
Professor Sikora, 74, is the founding dean of the University of Buckingham Medical School and a former clinical director of cancer services for Hammersmith and Charing Cross
This was despite the fact that hundreds of supporters — families and patients whom Professor Stebbing had treated either on the NHS or privately, and eminent colleagues — rallied to his cause, arguing that this verdict was unjust and testifying to his life-saving work.
The MPTS panel suspended Professor Stebbing for nine months, so he was unable to care for his 150 patients. The GMC had wanted more — it had pressed for him to be struck off completely.
And now the GMC has put Professor Sikora under threat of being struck off, too. He and another expert oncology witness who testified in Professor Stebbing’s defence have been served with notice from the GMC that they are now under investigation. The GMC will not tell them why.
‘Three months after the hearing had ended, I and the other defence expert received letters from the GMC saying our fitness to practise is under investigation,’ Professor Sikora told Good Health.
‘There’s been no hint of what we’d done wrong. They only sent 5,000 pages of transcript from Professor Stebbing’s disciplinary hearing.’
Professor Sikora, 74, is the founding dean of the University of Buckingham Medical School and a former clinical director of cancer services for Hammersmith and Charing Cross.
He has also been a member of the UK Health Department’s Expert Advisory Group on Cancer and the head of the World Health Organisation’s cancer programme. Described as a world expert on cancer, he has published more than 300 scientific papers and written or edited 20 books.
‘It’s the first time in my life I have ever been in trouble with the GMC,’ he says.
The GMC’s letter says: ‘On the basis of the information currently available, we’ve identified areas of good medical practice that have been called into question. We need to find out more information to see if this is correct and, if so, whether your fitness to practise medicine is potentially impaired. Our investigation will involve gathering more information about the allegations that have been raised and your practice as a whole.’
Dr Max Pemberton, a Daily Mail columnist and a full-time NHS psychiatrist, knows only too well how the GMC can subject innocent practitioners to lengthy, stressful investigations that are entirely unjustified. ‘I was referred to the GMC by a patient who made an incredibly serious allegation that I had assaulted them while assessing them in A&E,’ he says
A GMC spokesperson told Good Health: ‘We are unable to provide further information about any cases unless or until they are referred to a full hearing.’
Professor Sikora feels, however, that he knows why he has been put under investigation.
‘The MPTS disciplinary panel didn’t like what I told them. I had an argument with the chairman,’ he says. ‘I had reasonably suggested that the GMC investigation had cherry-picked 12 cancer patients’ cases out of the many hundreds that Professor Stebbing had successfully treated.
‘I pointed out that those 12 cases were a selected sample of patients who all did badly. But the chairman insisted that was not true. He actually shouted at me at one point. I was accused of misleading the tribunal.
‘But as a witness I was simply exercising my right to express my sincerely held, honest belief,’ Professor Sikora adds.
During the hearing, Professor Sikora admitted to mistakenly telling the tribunal he’d obtained summaries of three of Professor Stebbing’s patients’ records himself. In fact, lawyers had provided Professor Sikora with the summaries four years before and Professor Sikora had forgotten this (blaming a ‘lapse of memory’).
He has complied with the GMC demand that he send them details of all his current paid work.
‘The GMC then wrote to all my employers telling them that I am under investigation,’ says Professor Sikora. ‘Of course they are all worried that I’ve done something wrong. How can giving tribunal evidence possibly affect my fitness to practise medicine?
‘This is witness intimidation and in a criminal court it would be illegal.’
That might sound like a strange thing for the GMC to do — and why does this matter to patients?
Critics of the GMC claim that it has a record of persecuting good doctors, while allowing bad and even dangerous practitioners to continue treating patients.
For example, in another recent disciplinary case the council has been publicly lambasted by medical leaders for prosecuting a doctor in an overzealous manner.
In May, Dr Manjula Arora, a Manchester GP, was suspended for a month after ‘dishonestly’ claiming she’d been promised a laptop. The GMC tribunal heard that Dr Arora had requested a laptop for work and been told by her employer’s medical director that no laptops were available, but that they would ‘note [her] interest when the next rollout happens’.
+4View gallery
The stress of undergoing lengthy, potentially career-threatening GMC disciplinary proceedings is borne out by the fact that the regulator’s own statistics show that 29 doctors died while under investigation or monitoring between January 1, 2018 and December 31, 2020 — 20 from natural causes, six from ‘external causes’ (of which five were suicides) and three from ‘unspecified reasons’ [File photo]
Dr Arora subsequently told an IT department colleague that she’d been told she could have a laptop ‘next time [one was] available’, adding that she’d been ‘promised’ one. Despite the tribunal acknowledging her ‘dishonesty was confined to the use of a single word on a single occasion’, and that the case involved no risk to patients, it was deemed that her actions constituted ‘serious misconduct’.
The ruling sparked outrage. The British Medical Association (BMA) called the decision to suspend her ‘incomprehensible’. Its then chair, Dr Chaand Nagpaul, said it was ‘no wonder those three letters — GMC — instil terror in doctors’.
Amid widespread protests, a month later the GMC admitted the suspension was wrong and has taken steps to restore Dr Arora’s full registration.
The Royal College of General Practitioners said: ‘We will be asking for answers as to why the case was allowed to get through the GMC’s screening processes and end in a fitness-to-practise hearing and a sanction.’
A spokesperson for Doctors’ Association UK, which represents frontline British medical staff, said that while justice had been served, ‘this does not discount the unnecessary stress to Dr Arora and the message sent to thousands of doctors that their regulatory body does not think twice before unjustly suspending them’.
Dr Max Pemberton, a Daily Mail columnist and a full-time NHS psychiatrist, knows only too well how the GMC can subject innocent practitioners to lengthy, stressful investigations that are entirely unjustified.
‘I was referred to the GMC by a patient who made an incredibly serious allegation that I had assaulted them while assessing them in A&E,’ he says.
‘The GMC investigation process took 11 months — despite the fact that two police officers were present throughout the assessment I’d performed; two other members of staff also accompanied me; and there was CCTV of the entire encounter which showed I didn’t even touch the patient, let alone assault them.’
Dr Pemberton says that during the investigation his sleep suffered and he lost so much weight ‘colleagues thought [he] was ill’.
‘Everyone who knew me and worked closely with me in my team knew it was ridiculous, but the management were more concerned and I was lucky to have a boss who stuck his neck out and insisted that I be allowed to continue to work unsupervised, as normal, despite the allegations and investigation.’
After months of silence, the GMC wrote Dr Pemberton a letter saying that it did not find evidence and that the case had been dropped. ‘No apology was given,’ says Dr Pemberton.
The stress of undergoing lengthy, potentially career-threatening GMC disciplinary proceedings is borne out by the fact that the regulator’s own statistics show that 29 doctors died while under investigation or monitoring between January 1, 2018 and December 31, 2020 — 20 from natural causes, six from ‘external causes’ (of which five were suicides) and three from ‘unspecified reasons’.
Dr Karen Ellison, a medicolegal consultant at the doctors’ indemnity organisation, the Medical Protection Society, told Good Health: ‘Day in, day out we see the psychological impact GMC investigations have on the doctors involved.
‘We also see the impact it has on their families, their pay, their reputations and their careers.’
She says that fitness-to-practise investigations ‘often take several months — and sometimes years — to conclude’. It took four years for the GMC’s disciplinary system to investigate Professor Stebbing, during which time he was suspended by HCA Healthcare, a private health firm for which he worked.
Lengthy investigative procedures might be justified if they resulted in the GMC protecting patients’ safety. However, recent evidence suggests otherwise.
In June, a public inquiry report criticised the GMC for wrongly reassuring a hospital trust that a neurologist it employed was safe to work with patients, when in fact he was misdiagnosing them and treating them incorrectly.
In 2018, Michael Watt, a consultant neurologist at Belfast Health and Social Care Trust, was at the centre of the largest ever patient recall in Northern Ireland. A review of more than 5,000 patients found that nearly one in five of his high-risk patients had received a diagnosis described as ‘not secure’.
Concerns about Michael Watt’s practice had been voiced back in 2006, but the inquiry concluded that a vital opportunity to stop him was missed in 2012 when the GMC, following an ‘inadequate investigation’, decided to take no action on a patient’s complaint against him.
Thus the trust, wrongly reassured of Michael Watt’s safety, let him continue to practise, said the inquiry chair, Brett Lockhart KC.
The GMC’s chief executive, Charlie Massey, said: ‘We acknowledge that during our investigations we could and should have done more to act on clinical concerns sooner and to share information more effectively with other organisations.’
In fact, five years ago the MPTS tribunal heard fresh allegations about Michael Watt’s fitness to practise. But after evidence that he had been thinking of suicide, the tribunal allowed him to remove himself from the medical register without a hearing.
The Professional Standards Authority, which oversees healthcare regulators, challenged the decision at the High Court in Northern Ireland, but a judge decided that the decision was not open to challenge.
Other lenient responses include the case of Dr Satyen Singhai, who a GMC tribunal heard was rushed to hospital in January 2019 after bingeing on cannabis, cocaine, whisky and the tranquillising drug diazepam, which he had not been prescribed.
He fell down the stairs, prompting his neighbour to call the police. When officers arrived they had to handcuff him due to his agitated state.
Dr Singhai was taken to A&E at St Helier Hospital in Carshalton, South London, and the consultant who treated him referred him to the GMC. At the hearing last October, he was told: ‘This conduct does not meet with the standards required of a doctor. It risks bringing the profession into disrepute and it must not be repeated.’
But he was only issued with a warning and was allowed to keep his job.
Dr Singhai’s representative told the GMC tribunal that Dr Singhai was dealing with ‘extreme’ stress and bereavement at the time and that he was an ‘excellent’ doctor.
Meanwhile, in May Dr Jigarkumar Dave, who had been suspended for nine months for beating his wife, was given permission to practise again.
At a criminal court in November 2019, the former cardiologist was convicted of assault, made subject to a community order and fined £331.
In July 2021, Dr Dave was suspended by a GMC tribunal. But in May, Paul Moulder, chair of the tribunal, allowed him to return to practice, saying: ‘The tribunal determined that the risk of repetition was extremely low and hence there was no risk to the health, safety and wellbeing of the public.’
He added: ‘The tribunal was satisfied that an ordinary member of the public, appraised of the facts of this case, and having regard to Dr Dave’s considerable insight and extensive remediation, would not be shocked or surprised to learn that Dr Dave was to be allowed to return to unrestricted practice.’
Meanwhile, Professor Sikora remains under the shadow of an inquiry that he believes focuses on the considered professional opinion he was asked to give at a GMC tribunal.
‘My professional indemnifier [i.e. insurer] is taking it very seriously and thinks that I will be put up before a disciplinary tribunal,’ he says.
‘The GMC desperately needs reforming. We need good people to feel wanted in the NHS, not hounded out on spurious grounds at great expense to the taxpayer.’
His opinion is echoed by Dr Nagpaul, who is calling for an independent review into the GMC to address the ‘systemic flaws’ in its disciplinary processes.
Professor Sikora adds: ‘I feel let down by the GMC. It has totally lost its way.
‘If I am hauled before a tribunal, the current pace of GMC investigations means that it won’t be held until 2026 at the earliest. I’ll be 78 then. It’s a bizarre thing to do at this stage in my career.’
Closing the feedback loop on GMC referrals.
Iacobucci (1) reports that the GMC is looking at referrals to the regulator, recognizing that most referrals come from the Responsible Officers (RO). (2) Referrals from RO are more likely to lead to an investigation than referrals from the public or other professionals.
The problem is that RO's are not appointed or employed by the GMC, they are controlled by the NHS. Often they also have the role of Medical Director and as such there is a conflict of interest between pursuing NHS policies and regulating the profession. (3) One such NHS policy against single handed GPs was highlighted by Dame Janet Smith in the Shipman enquiry and it is worrying to think this may have played a part in referrals of single handed GPs. (4)
I welcome the intention of the GMC to examine the handling of referrals. A simple addition to the proposals would be for the GMC to close the feedback loop on referrals and evaluate the outcome of any allegation made. The GMC could evaluate allegations that subsequently proved unsubstantiated and investigate ROs that make false allegations or use the revalidation system to bully colleagues. (5, 6) Furthermore the GMC could revise their policy to take any allegation of dishonesty at face value and organise a tribunal without first attempting to assess whether allegations of dishonesty are false. (7) Closing the feedback loop would go a long way to address the concerns highlighted in the Hooper report about retaliatory referrals and lack of the GMC investigating the background context of the referral and the use of the revalidation tools to victimise doctors. (8)
The current proposals to examine the data against bench marks will not be sensitive enough to detect outliers due to the large standard deviations inherent to the small number of referrals per RO, nor will they detect retaliatory referrals due to a broken down personal relationship between RO and the subject.
(1) Gareth Iacobucci. GMC sets targets to end disproportionate complaints against ethnic minority doctor. BMJ 2021;373:n1269. https://www.bmj.com/content/373/bmj.n1269
(2) Aisha Majid. What lies beneath: getting under the skin of GMC referrals. BMJ 2020;368:m338 https://www.bmj.com/content/368/bmj.m338
(3) Novak, S.A. Why is bullying rife in the NHS? Are doctors and nurses any nastier than comparable professionals? Can you regulate for better standards of behaviour? https://www.bmj.com/content/350/bmj.h2300/rr-2
(4) Dame Janet Smith, Shipman enquiry, fifth report. https://webarchive.nationalarchives.gov.uk/20090808163839/http://www.the...
(5) Wilmshurst, The role of whistleblowers in improving the integrity of the evidence base. https://www.youtube.com/watch?v=Xze-yPubFIY
(6) Wilmshurst. Plea bargaining at the General Medical Council BMJ 2011;342:d2713. https://www.bmj.com/content/342/bmj.d2713
(7) GB Professionalism & Keeping out of Trouble, General Medical Council. https://www.youtube.com/watch?v=veLGakjY9SU (26 minute mark: "this will always lead to some kind of tribunal")
(8) Sir Anthony Hooper. The handling by the General Medical Council of cases involving whistleblowers https://www.gmc-uk.org/-/media/documents/hooper-review-final-60267393.pdf
Competing interests: No competing interests
31 May 2021Henry F CallahanretiredLeeds
22 May 2021
S. Ali
Not working as a doctor
NHS
Birmingham
Dear Editor
I found the related direct email from Dame Marx GMC Chair, on the face of it very positive but overall given history, left wondering is this just ongoing lip-service, as the right hand does not know what the left hand does in an organisation not fit for purpose. The Q&A with Mr Massey appears to show the GMC have been increasingly pushed rather than this being a natural output of a good regulator. There appears some understanding of the causes but overall a fundamental flaw given that they want to look at final year medical school data amongst others, rather than see it for what it is, racism due to ethnicity - as such a better measure instead of origin of primary medical qualification is ethnic background. Various FOI requests show it is easier to get the names of doctors rather than anonymise them by a measure of ethnic background. Seems more pushing is needed by everyone in the profession and outside including the #BlackLivesMatter movement.
My own worry, given fundamental problems and the nature of society we are in. Is that not will, but are the GMC acting like a supermarket in, artificially further reducing or ignoring the evidence level to consider actions against Asian and Black doctors whilst increasing the level needed to consider a complaint against a white doctor with token exemptions – to then show improvements when FTP referrals goes back to pre-pandemic levels. I say this having had my own complaints against doctors with multiple incompetent deaths ignored but then finding after writing similar comments and highlighting prospective employers candidly, that I am now find myself again subject to a Fitness to Practice Investigation for now ‘character’ of disclosures with pre-application discussions for non-medical employment (which highlight GMC discrimination and failures factually but in a negative matter of fact light).
This is a well written article, but I do wonder if the author was obviously Black or Asian would he be subject to Fitness to Practice for writing the article and bringing further disrepute onto the GMC. I am glad the majority of us (including author) have a common understanding in good medical practice and are supportive to those marginalised by injustice.
Competing interests: Subject to 4th GMC FTP investigation at lower threshold
The General Medical Council has set itself new targets to eliminate disproportionate complaints from employers about ethnic minority doctors by 2026, and to eradicate disadvantage and discrimination in medical education and training by 2031.
Announcing the move on 18 May, the GMC acknowledged “long standing concerns” about the problems within healthcare and said there was “clear evidence of disproportionality”12 over time.
It noted that doctors from ethnic minorities are twice as likely as white doctors to be referred to the GMC by their employers for fitness to practise concerns, while the referral rate for doctors who qualified outside of the UK is three times higher than that for UK doctors.
In education and training, exam pass rates show a 12% difference between white and ethnic minority trainees who graduated in the UK, and a 30% gap for overseas graduates.
The regulator set a range of measures to help meet the targets:
Wendy Reid, director of quality and education and medical director at Health Education England, said that her organisation would be “working with our stakeholder partners across the system to help support the GMC achieve these important goals.”
But Aneez Esmail, professor of general practice at the University of Manchester, who co-authored a landmark BMJ paper in 1993 which found that ethnic minority doctors were less successful than white doctors in securing specialty training posts, said that while targets were a good thing, they needed to be more ambitious.
He said, “The unfairness in referrals could stop tomorrow. They could say ‘We’re not going to consider this referral unless you show to us that you’ve done X, Y, Z, and so on.’ I know differential attainment is more complicated and will take longer, but give them five years to solve it rather than ten, which is allowing unfairness to continue for too long. The GMC is awash with data. What are they doing with it?”
Mala Rao, professor of public health at Imperial College London and a medical adviser to the NHS Workforce Race Equality Standard, described the announcement as “a significant milestone in the recent NHS journey towards race equality in medicine,” but added, “The GMC, NHS England, and all relevant partners will need to work together to make these goals a reality.”
The BMJ spoke to the GMC’s chief executive Charlie Massey about the announcement.
It has been a longstanding concern. But my perspective is that over the past year, there’s been much more of an awakening around the matters of inequality in the NHS and society more generally, and that’s created a real impatience at my end about the need for change. I have described the inequality as shameful and I stand by that. A lot of the conversations I have with NHS leaders tell me that there is more of a determination and a commitment to make progress on this agenda. And within the GMC, over the past year, we’ve focused on what an ambitious agenda looks like in terms of equality, diversity, and inclusion, both in terms of our role as a regulator and as an employer. The targets are quite different to things we’ve done before—they are ambitious but also require us to exert influence and leverage over others. The reason we’re using the word “eliminate” is because I want the debate to be about how, rather than whether, we can do this. The inequality we have is desperately bad for the profession but it’s also bad for patients.
We have some levers in terms of the way in which we engage with responsible officers about clinical governance and environments. But we want to extend our soft influence—for example, by talking to boards where we think that the environments that they have responsibility for are not producing the standards of equality that we or they would want. The NHS world is an incredibly complex one, and our success is going to be determined by the way we can collaborate, align, and influence each other. The more we as regulators can create a more consistent view about what good looks like, the better able we’re going to be to achieve it.
Most referrals to us from employers come through responsible officers. Over the past few years we have significantly ramped up our outreach capacity—people who engage directly with responsible officers, NHS England and Improvement, and others to provide support. We also provide training to doctors locally. A big element is to ensure that responsible officers are referring doctors properly. Sometimes that will mean that we’re saying that although something may have gone wrong, we think it’s something that you should be trying to resolve locally. But the other conversation is about trying to support responsible officers to create better environments for all the doctors over whom they have oversight. For example, we know that induction is often inadequate and inconsistent. How can we improve the quality, consistency, and availability of induction within trusts, and clinical environments?
We’re measuring fitness to practise disproportionality in two ways. We’re looking at referral rate data by responsible officer, but also at the difference in referral rates at a national level. For both of those we’re looking at ethnicity and where people got their primary medical qualification. The differential attainment target has more of a basket of measures. There are education performance measures that monitor the progress of undergraduates through their medical education, so we’ll use that to look at the relative difference in progression. We’ll be looking at medical schools’ final exam pass rates. There is then some quite important data in terms of preparedness that doctors tell us when they’re going through the foundation programme. We’ve also got our national training survey data where we ask questions about inclusivity and support. And then we’ve got the progression through postgraduate training, so we’ll have the data on unsatisfactory outcomes and we’ll also have the specialty exam pass rate.
That’s something I want to get to through a process of dialogue. You’ve got many different specialty specific exams, some quite complicated matters in relation to group dynamics, the variation of feedback and peer support. You’ve also got some structural problems in that trainees who fare less well in exams are less likely to get their first choice training location, and, of course, those trainees are more likely to be from ethnic minorities. The GMC has important responsibilities, as do the statutory education bodies, the postgraduate deaneries, the colleges. We need to sit down with all of those. I wouldn’t rule having some difficult conversations about what the specific ambitions and the level of those ambitions should be. But my starting point is that none of those bodies are in the wrong place in terms of wanting to really tackle this matter.
Opinion
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1346 (Published 27 May 2022)Cite this as: BMJ 2022;377:o1346
Many in the medical profession have rightly reacted with outrage at hearing that the Medical Practitioners Tribunal Service has suspended Manjula Arora, a GP in Manchester, relating to her request in December 2019 for a work laptop for the purpose of triaging patients.1 Astonishingly, Arora was suspended for “dishonesty” in using the single word “promised” in a phone call to her IT department, based on her understanding of an earlier email that a laptop would be provided when available. This was in spite of the fact that Arora had stated that the IT department should confirm her understanding of what she had been told.
This case epitomises the systemic flaws in the entire referral pathway to the medical profession’s regulator the General Medical Council (GMC)—ranging from the decision by an employer to refer, through to the decision to investigate, the process of investigation and finally the tribunal hearing.
Being notified and being investigated by the GMC can be one of the most traumatic experiences in a doctor’s life. A past survey by the Medical Protection Society highlighted that 72% of respondents felt that their GMC investigation had a detrimental impact on their mental and/or physical health, and, tragically, between Jan 2019 - Dec 2020, 29 doctors died while under investigation, of which five deaths were confirmed as death by suicide.23 There is therefore a moral imperative that the GMC as a regulator needs to be used proportionately, appropriately, and only when necessary.
However, problems can begin at the very onset of a decision to refer, with concerns about inconsistency and unfairness of referrals from employers. Ethnic minority doctors are already referred at twice the rate of white doctors, and international medical graduates are referred at three times the rate as UK trained doctors.4 The GMC itself recognises this inequality and has set a deadline for this to be eradicated by 2026.5
Further, the existence of inherent bias against ethnic minority doctors has been demonstrated by a recent study which showed that anonymised case details and scrutiny by an independent panel before a formal referral to the GMC eliminates the disproportionality in referrals between ethnic minority doctors and white doctors.6
Upon receipt of a referral there are further concerns about the objectivity and fairness in the GMC’s decision to investigate. In the recent landmark employment tribunal ruling against the GMC for race discrimination, brought by Omer Karim, a consultant urological surgeon, it was found that the GMC was looking for material to support allegations “however trivial, however old, and however much they contradicted accounts from those who actually knew about the claimant’s conduct and competence […] rather than fairly assessing the matters presented.”7 In Arora’s case, the decision to investigate seems entirely disproportionate given that to any reasonable person the allegations made against Arora should have been handled locally with understanding and compassion.
As a result, the BMA has called for the immediate safeguard of an external scrutiny panel to assess each potential employer referral to ensure that it is fair and objective, and consider whether the issue could be more appropriately dealt with locally and swiftly.8 This is especially important given the mental turmoil and uncertainty resulting from a GMC referral. It is not uncommon that these cases stretch on for years, and in this case, Arora waited an inordinate two years and three months, much longer than the GMC’s own standard of 12 months.
The final stage in the pathway is the MPTS tribunal, where this case raises further concerns about objectivity and fairness in reaching decisions. Reading the Tribunal’s determination, the inherent adversarial process of hearings appears to be driven by the GMC’s focus on winning the case as opposed to a sensitive approach to assessing an allegation based upon evidence.
For Arora, this involved being subjected to a cross examination by a barrister on the semantics of her use of the single word “promised.” For this simple miscommunication, in the hearing the GMC extraordinarily accused her of bringing “the medical profession into disrepute.”
The Tribunal itself admitted that “Dr Arora’s misconduct was a single incident in relation to the use of a single word, with no evidence of any other similar episodes of dishonesty before or after.” It further stated that “Dr Arora had not set out to be dishonest, and that she had not set out to mislead.” The GMC representative “acknowledged Dr Arora was a person of good character.”
It is therefore all the more perplexing that the tribunal ultimately ruled that Arora’s fitness to practice was “impaired by purpose of her misconduct” and suspended her on the basis that it “would send an appropriate message to the medical profession and the wider public.” In arriving at this conclusion, the tribunal stated that an informed member of the public would consider this suspension “reasonable.”
It is incomprehensible how preventing Arora from providing care to patients for a month at a time of exceptional NHS pressures, over a semantic disagreement on the use of a single word, would be considered “reasonable” to members of the public.
Ultimately, far from having any positive impact on the public’s confidence in doctors, this determination has exacerbated fear and distrust among the medical profession, already afraid that the regulatory process is inherently stacked against them.
This entire case demonstrates how the current system is structurally disproportionate, lacks timeliness, with insufficient checks and balances, and is manifestly unjust. The GMC has since indicated that it will seek to understand whether there are lessons to learn from this case. However, this falls well short of what is needed. The catalogue of concerns from the point of referral, GMC investigation to a tribunal hearing further supports the BMA’s call for a root-and-branch, independent review with radical reform of the entire pathway.9 Nothing short of this can secure justice and fairness in medical regulation.
Copyright © 2023 GMC-Watch - All Rights Reserved.